Dr. Colin Goudelocke, MD

I am a urologist practicing at Ochsner Medical Center in New Orleans, Louisiana. After finishing my Urology residency, I completed a Female Urology fellowship at the Medical University of South Carolina in Charleston, South Carolina. I am Board-Certified in Urology and Sub-Specialty Certified in Female Pelvic Medicine and Reconstructive Surgery (FPMRS).

Over the last 9 years, I began one of the nation’s first dedicated clinics focusing on overactive bladder (OAB) and incontinence, The OAB Clinic at Erlanger. There I was able to develop a comprehensive program that addressed all of the needs of our bladder patients, providing all levels of care in one convenient location.

I am very pleased to return to my home in Louisiana to continue the progress I made both in caring for patients with the latest technology and information as well as advancing our understanding of bladder health with a busy research program. It is exciting to bring the experience I gained from founding The OAB Clinic to patients throughout the Gulf South.

Education

B.S. – Louisiana State University 

M.D. – Louisiana State University School of Medicine 

Training

Internship – Surgery: Louisiana State University Health Sciences Center Shreveport, LA  (2004-2005)

Residency – Urology: Louisiana State University Health Sciences Center  Shreveport, LA (2005-2009)

Fellowship – Female Pelvic Medicine and Reconstructive Surgery: Medical University of South Carolina, Charleston, SC (2009-2010)

Faculty Appointments

Assistant Professor – Medical University of South Carolina; Department of Urology (2010-2011)

Assistant Professor – University of Tennessee at Erlanger; Department of Urology (2015-2019)

Physician – Ochsner Medical Center; Department of Urology (2019-Present)

Specialty Certifications

Urology – American Board of Urology

Female Pelvic Medicine and Reconstructive Surgery – American Board of Urology

Abstracts and Presentations

Goudelocke C, Figueroa J. Measuring the effects of Azaftig on adipocyte lipolysis  Louisiana State University Medical Center Summer Research Forum, New Orleans, LA.  August 25, 2001.

Goudelocke C, Haverkorn R, Williams BJ, Tareen B, Bologna R, Gomelsky A. Commercial prolapse repair “kits” vs. traditional transvaginal prolapse repairs: A comparison of efficacy and cost.

  • Society for Urodynamics and Female Urology, San Diego, CA.  February 23, 2007
  • Southeastern Section of the AUA, Orlando, FL.  March 10, 2007
  • Ohio Urologic Society, Columbus, OH.  March 17, 2007.
  • Louisiana State Urological Society, Lafayette, LA.  April 15, 2007.
  • AUA Annual Meeting, Anaheim, CA.  May 22, 2007.

Park S, Goudelocke C, Cadeddu J, Shingleton B.  Evaluation of ureteropelvic junction injury after intentional ablation injury.  Southeastern Section of the AUA, Orlando, FL.  March 8, 2007.

Goudelocke C, Ankem M. Bilateral laparoscopic retroperitoneal adrenalectomy in the prone position. 25th World Congress of Endourology and SWL. Cancun, Mexico. October 2007 (Video)

Goudelocke C, Haverkorn R, Williams BJ, Gomelsky A. Risk factors for persistent or recurrent stress urinary incontinence after transobturator slings.

  • Louisiana State Urological Society, New Orleans, LA. April 20, 2008
  • Southeastern Section of the AUA, San Diego, CA. March 8, 2008

Haverkorn M, Goudelocke C, Williams BJ, Kubricht WS, Gomelsky A. Is obesity truly a risk factor for failure in sling surgery for stress incontinence in women?

  • Society for Urodynamics and Female Urology, Miami, FL.  March 1, 2008
  • Southeastern Section of the AUA, San Diego, CA. March 9, 2008
  • AUA Annual Meeting, Orlando, FL.  May 19, 2008

Goudelocke C, Williams BJ, Kubricht WS, Gomelsky A. Determinants of failure after sling surgery for female stress urinary incontinence.

  • Southeastern Section of the AUA, Mobile, AL. March 26, 2009
  • Louisiana State Urological Society, Shreveport, LA.  April 18, 2009
  • AUA Annual Meeting, Chicago, IL. April 28, 2009
  • ICS Annual Meeting, San Francisco, CA. September 30, 2009

Goudelocke C, Rovner E. Trans-vaginal bladder neck closure with posterior urethral flap

  • Society for Urodynamics and Female Urology, St. Petersburg, FL.  February 26, 2010
  • AUA Annual Meeting, San Francisco, CA. May 28, 2010

Goudelocke C, McIntyre M, Nickles W, Rovner E. Effects of estrogen treatment on mesh-augmented vaginal prolapse repair

  • Society for Urodynamics and Female Urology, Fellows Forum. February 25, 2010
  • AUA Annual Meeting, San Francisco, CA. May 28, 2010

Goudelocke C, Rovner E. Urodynamic “area under the curve” as a potential prognostic factor in neurogenic bladder dysfunction

  • Society for Urodynamics and Female Urology, February 26, 2010
  • AUA Annual Meeting, San Francisco, CA. May 28, 2010

Gilchrist A, Goudelocke C, and Rovner E. Can Videourodynamics predict sling location in patients with SUI following midurethral sling?

  • Society for Urodynamics and Female Urology, March 3, 2011

Colhoun A, Goudelocke C, and Rovner E. Does reproduction of symptoms on urodynamics influence patient outcomes after treatment?

  • Society for Urodynamics and Female Urology, March 5, 2011

Singh A, Hunt S, Wheelock A, Galen N, Goudelocke C, Class J. A comparison of robotic and open radical cystectomy for urothelial carcinoma in octogenarians.

  • World Congress of Endourology, October 2013

Singh A, Hunt S, Wheelock A, Galen N, Goudelocke C, Class J. Open and robotic nephron sparing surgery for T1a or greater renal cell carcinoma: a single center experience.

  • World Congress of Endourology, October 2013

Singh A, Hunt S, Wheelock A, Galen N, Goudelocke C, Class J. Outcomes of robotic-assisted ureteroneocystostomy in the management of gynecological surgery associated ureteric complications.

  • World Congress of Endourology, October 2013

Singh A, Hunt S, Wheelock A, Galen N, Goudelocke C, Class J. Outcomes of robotic-assisted ureteroneocystostomy in the management of gynecological surgery associated ureteric complications.

  • World Congress of Endourology, October 2013

Conner,J, Long,A, Goudelocke, C. Optimized Sacral Neuromodulation lead placement is feasible and does not increase operative times.

  • Southeastern Section of AUA, March 2018
  • Society for Urodynamics, Pelvic Medicine and Urogenital Reconstruction, March, February 2017
  •  

Conner,J, Long,A, Goudelocke, C. A novel sacral neuromodulation infection protocol is associated with reduction in device infection.

  • Southeastern Section of AUA, March 2018
  • Society for Urodynamics, Pelvic Medicine and Urogenital Reconstruction, March, February 2017

Goudelocke, C, Gurtner, K, Couvaras, A, Long, A. A “mixed” motor sacral neuromodulation lead placement results in higher implant rates.

  • In submission September 2019

Goudelocke, C, Gurtner, K, Couvaras, A.  The relationship between motor and sensory responses in sacral neuromodulation.

  • In submission September 2019
  • In submission September 2019

Goudelocke, C, Jahn, H.  Sacral neuromodulation sensory response stabilizes early after implantation.

Publications

Rovner E and Goudelocke C. “Interstitial Cystitis.” eMedicine. Medscape, 8 Nov. 2009 <http://emedicine.medscape.com/>.

Rovner E and Goudelocke C. “Which injectable to use in the treatment of intrinsic sphincter deficiency”. Current Opinions in Urology, 2010. 20:296-301.

Rovner E and Goudelocke C. “Urodynamics in the evaluation of overactive bladder”. Current Urology Reports, 2010. Volume 11, Issue 5.

Rovner E and Goudelocke C. “Management of pelvic organ prolapse”. Current Opinions in Urology, 2010. 20: 490-494.

Lebed B, Goudelocke C, Gilchist A, and Rovner E. “Trans-vaginal Bladder Neck Closure with Posterior Urethral Flap for the Devastated Urethra” Urology, 2011. 78(1):208-12.

Andrew Colhoun BS, Colin Goudelocke MD, Eric S. Rovner MD “Reproduction of Female Lower Urinary Tract Symptoms on Urodynamics” LUTS: Lower Urinary Tract Symptoms, Volume 4, Issue 2, pages 59-62, May 2012

Lectures

Sept. 20, 2008  “Urinary Tract Infections: Diagnosis and Management” SUNA – North Louisiana Chapter, Shreveport, Louisiana

2009-2010  Combined Departments of Urology and Gynecology Conference: Monthly Fellow Lecture Series

Nov. 6, 2010  “Diabetes and Sexual Dysfunction” Community Health Day Conference and Health Expo Charleston, SC

February 7, 2012   “Intestinal Segments in Urinary Diversion” General Surgery Grand Rounds, University of Tennessee, Chattanooga, Tennessee

June 2012   “Bladder Dysfunction in Primary Care” Family Medicine Update Conference, Department of Family Medicine, University of Tennessee, Chattanooga, Tennessee

December 7, 2012   “Bladder Pain Syndrome/Interstitial Cystitis” Department of Obstetrics and Gynecology Grand Rounds, University of Tennessee – Chattanooga, Tennessee

March 1, 2013           “Fundamentals of Urodynamics” Department of Obstetrics and Gynecology Grand Rounds, University of Tennessee – Chattanooga, Chattanooga, Tennessee

June 13, 2013            “Urinary Incontinence in Primary Care” Family Medicine Update Conference, Department of Family Medicine, University of Tennessee – Chattanooga, Chattanooga, Tennessee

October 31, 2014      “Complications of Synthetic Mesh”. Department of Obstetrics and Gynecology Grand Rounds, University of Tennessee – Chattanooga, Chattanooga, Tennessee

August 31, 2015    “Advanced Therapies for Overactive Bladder” Department of Urology Grand Rounds. University of Tennessee – Chattanooga, Tennessee

August 29, 2016   “Expanding Roles of Neuromodulation” Department of Urology Grand Rounds, University of Tennessee –Chattanooga, Tennessee

June 15, 2017   “Urinary Incontinence and Pelvic Organ Prolapse for the Primary Care Provider” 32nd Annual Family Medicine Update, Chattanooga, Tennessee

September 28, 2017 “Management of Recurrent Urinary Tract Infections”  Department of Family Medicine, University of Tennessee – Chattanooga, Tennessee

November 16, 2018 “Optimization of Sacral Neuromodulation” Ochsner Clinic, Department of Urology, New Orleans, Louisiana

June 14, 2019   “Overactive Bladder in Primary Care”  33rd Annual Family Medicine Update, Chattanooga, Tennessee

Clinical Trials

2009 – 2011    Contura(Sub-investigator): A Single-Masked, Randomized, Multi-Center, 2-Arm Parallel Study Comparing the Safety and Effectiveness of Bulkamid® and Contigen® as Bulking Agents for the Treatment of Stress Urinary Incontinence in Females

2010 – 2011    Ethicon (Sub-investigator): Pilot Clinical Trial to Study the Effectiveness of a four-week exposure to a transcutaneous, high-frequency, amplitude-modulated, non-invasive neurostimulation device on urgency (urinary) incontinence in subjects with idiopathic overactive bladder (OAB)

2011-2012      Ferring International PharmaScience Center (Sub-investigator): A Multi-centre, Randomised, Double-blind, Placebo-controlled, Parallel-group Trial with an Open-label Extension to Demonstrate the Efficacy and Safety of Desmopressin Orally Disintegrating Tablets for the Treatment of Nocturia in Adult Males

2011-2012    Endo Pharmaceuticals (Sub-investigator): Mitomycin C EN3348-303

2016-2018   Astellas (Principal Investigator):OAB PILLAR 178-MA-1005

2017-2019     Medtronic (Principal Investigator) Interstim Amplitude Study NCT03335761

2018-2019   Medtronic (Principal Investigator) SNM Trial Phase Study

2019-Present    Medtronic (Principal Investigator) SNM Trial Phase II Study